ProteoThera, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States2-10 Employees
ProteoThera, Inc. is an early-stage biotechnology company based in Newton, Massachusetts. It is developing a proprietary platform that fuses therapeutic proteins to tissue matrices to influence where and how drugs act. The company focuses on autoinflammatory diseases and tissue regeneration, aiming to improve efficacy and safety by localizing activity and reducing systemic exposure. The initial development priority is PRT-1000, an MB-conjugated Interleukin-1 Receptor Antagonist for acute gout pain. The MB targeting technology originated at Brigham and Women's Hospital and Harvard Medical School, and the company operates with a small team in the Newton area.